Published in J Biol Chem on November 11, 2016
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
On the origin of cancer cells. Science (1956) 49.55
Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44
Sequence and structure of a human glucose transporter. Science (1985) 8.03
Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer (2002) 7.79
Simple allosteric model for membrane pumps. Nature (1966) 7.78
Glycolysis inhibition for anticancer treatment. Oncogene (2006) 6.55
Inability of diffusion to account for placental glucose transfer in the sheep and consideration of the kinetics of a possible carrier transfer. J Physiol (1952) 5.70
Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature (1989) 4.95
Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature (1988) 3.57
Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab (2007) 3.10
Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues. J Biol Chem (1989) 2.81
Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther (2008) 2.79
Ras-dependent carbon metabolism and transformation in mouse fibroblasts. Oncogene (2006) 2.57
The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem (2000) 2.55
Crystal structure of the human glucose transporter GLUT1. Nature (2014) 2.12
Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab (2002) 1.82
Structural requirements for binding to the sugar-transport system of the human erythrocyte. Biochem J (1973) 1.73
A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther (2012) 1.55
Testing and characterizing the simple carrier. Biochim Biophys Acta (1974) 1.44
Evidence for two asymmetric conformational states in the human erythrocyte sugar-transport system. Biochem J (1975) 1.38
Glucose transporter function is controlled by transporter oligomeric structure. A single, intramolecular disulfide promotes GLUT1 tetramerization. Biochemistry (1995) 1.35
Asymmetry of the hexose transfer system in human erythrocytes. Comparison of the effects of cytochalasin B, phloretin and maltose as competitive inhibitors. J Physiol (1978) 1.34
Cytochalasin B and the kinetics of inhibition of biological transport: a case of asymmetric binding to the glucose carrier. Biochim Biophys Acta (1978) 1.34
The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev (2009) 1.31
A highly conserved hydrophobic motif in the exofacial vestibule of fructose transporting SLC2A proteins acts as a critical determinant of their substrate selectivity. Mol Membr Biol (2007) 1.27
Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells. Biochim Biophys Acta (2009) 1.25
Novel Observations From Next-Generation RNA Sequencing of Highly Purified Human Adult and Fetal Islet Cell Subsets. Diabetes (2015) 1.21
Molecular basis of ligand recognition and transport by glucose transporters. Nature (2015) 1.17
Docking studies show that D-glucose and quercetin slide through the transporter GLUT1. J Biol Chem (2005) 1.17
The red blood cell glucose transporter presents multiple, nucleotide-sensitive sugar exit sites. Biochemistry (2001) 1.13
Equilibrium ligand binding to the human erythrocyte sugar transporter. Evidence for two sugar-binding sites per carrier. J Biol Chem (1987) 1.10
Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia (2008) 1.07
ATP-dependent substrate occlusion by the human erythrocyte sugar transporter. Biochemistry (2000) 1.07
GLUT1 deficiency syndrome 2013: current state of the art. Seizure (2013) 1.06
Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response. Cell Death Dis (2013) 1.05
Functional architecture of MFS D-glucose transporters. Proc Natl Acad Sci U S A (2014) 1.04
Human erythrocyte sugar transport is incompatible with available carrier models. Biochemistry (1996) 1.04
Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis. Compr Physiol (2012) 1.01
Changes in the intrinsic fluorescence of the human erythrocyte monosaccharide transporter upon ligand binding. Biochemistry (1982) 1.00
Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells. Oncotarget (2015) 0.99
Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine. Am J Physiol Gastrointest Liver Physiol (2004) 0.99
Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1. Br J Pharmacol (2003) 0.99
Asymmetry of the hexose transfer system in human erythrocytes. Experiments with non-transportable inhibitors. J Physiol (1978) 0.98
The human erythrocyte sugar transporter presents two sugar import sites. Biochemistry (1999) 0.97
Ultrastructure of human erythrocyte GLUT1. Biochemistry (2006) 0.96
Sequence determinants of GLUT1 oligomerization: analysis by homology-scanning mutagenesis. J Biol Chem (2013) 0.96
Glucose transporter 1 deficiency syndrome and other glycolytic defects. J Child Neurol (2002) 0.92
Inhibitions of sugar transport produced by ligands binding at opposite sides of the membrane. Evidence for simultaneous occupation of the carrier by maltose and cytochalasin B. Biochemistry (1991) 0.91
An experimental test for cyclic versus linear transport models. The mechanisms of glucose and choline transport in erythrocytes. J Biol Chem (1981) 0.91
Sequence determinants of GLUT1-mediated accelerated-exchange transport: analysis by homology-scanning mutagenesis. J Biol Chem (2012) 0.89
Anomalous asymmetric kinetics of human red cell hexose transfer: role of cytosolic adenosine 5'-triphosphate. Biochemistry (1986) 0.89
Caffeine inhibits glucose transport by binding at the GLUT1 nucleotide-binding site. Am J Physiol Cell Physiol (2015) 0.89
Reptation-induced coalescence of tunnels and cavities in Escherichia Coli XylE transporter conformers accounts for facilitated diffusion. J Membr Biol (2014) 0.88
A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models. Oncotarget (2015) 0.87
Mechanisms for the facilitated diffusion of substrates across cell membranes. Biochemistry (1991) 0.86
Human erythrocytes transport dehydroascorbic acid and sugars using the same transporter complex. Am J Physiol Cell Physiol (2014) 0.84
alpha- and beta-monosaccharide transport in human erythrocytes. Am J Physiol Cell Physiol (2008) 0.81
Implications of aberrant temperature-sensitive glucose transport via the glucose transporter deficiency mutant (GLUT1DS) T295M for the alternate-access and fixed-site transport models. J Membr Biol (2013) 0.80
Novel inhibitors of basal glucose transport as potential anticancer agents. Bioorg Med Chem Lett (2010) 0.79